arrow
S

Stuart J. Connolly

mcmaster university
H指数:134
被引数:8.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Atrial fibrillation and atherosclerosis cause different vascular brain lesions on magnetic resonance imaging

房颤和动脉粥样硬化导致磁共振成像上不同的血管性脑损伤。

2025-08-012
PRE
Risk of Stroke or Systemic Embolism According to Baseline Frequency and Duration of Subclinical Atrial Fibrillation: Insights From the ARTESiA Trial

根据亚临床房颤的基线频率和持续时间,中风或全身性栓塞的风险: 来自ARTESiA试验的见解

2024-11-260
PRE
Prevalence and Distribution of Intracranial Vessel Occlusion on Angiography and Its Association with Functional Outcome in Patients with Atrial Fibrillation Presenting with Ischemic Stroke

心房颤动伴缺血性卒中患者血管造影中颅内血管闭塞的发生率和分布及其与功能预后的关系

2024-09-302
OA
Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AF

房颤患者口服抗凝药的残余卒中风险: 联合房颤患者水平的荟萃分析

2024-09-032
OAAI
Perioperative management and outcomes in patients receiving low-dose rivaroxaban and/or aspirin: a subanalysis of the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial

接受小剂量利伐沙班和/或阿司匹林的患者的围手术期管理和结局: 使用抗凝策略的患者的心血管结局 (COMPASS) 试验的子分析

2024-08-010
OAAI
Mortality and Morbidity in Adults With Rheumatic Heart Disease

成人风湿性心脏病的死亡率和发病率

2024-07-092
PRE
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
2024-05-1640
PRE
Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials

直接口服抗凝剂预防装置检测到的房颤患者的卒中: noah-afnet 6和ARTESiA试验的研究水平荟萃分析

2024-03-2678
OA
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation

非维生素k拮抗剂口服抗凝剂与华法林在体重指数和体重范围内的有效性和安全性: 对房颤患者的4项随机临床试验的个体患者数据荟萃分析

2024-03-197
OA
Andexanet alfa versus non-specific treatments for intracerebral hemorrhage in patients taking factor Xa inhibitors - Individual patient data analysis of ANNEXA-4 and TICH-NOAC
2024-03-0810
PRE